Organon & Co.
Organon & Co. is a pharmaceutical company with significant physician payment activity ($4.5M in 2024) and a single, high-structural-alignment political donation to a key Senate health appropriator.
BusinessWhat OGN does
Organon is a global healthcare company focused on women's health, biosimilars, and established brands. Its revenue is derived from the development and commercialization of pharmaceutical products across these therapeutic areas. The company engages in substantial payments to healthcare professionals, with $4.5M across 45,758 payments in 2024 per `get_political_influence.doctor_payments`.
12 months past · 3 months futureOGN activity timeline
Executive Branch ConflictsOGN held by Trump-administration officials
Lifetime Government AwardsOGN federal contracts
OGN doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding OGN
Politicians Trading OGNMembers of Congress with recent OGN positions
Congressional TradesWho in Congress is trading OGN
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting OGNLive legislation impacting this stock
Political ProfileWhere OGN sits in Washington
[object Object]
STRUCTURAL: Strong single-point alignment with Senate health appropriations/policy power via $5K donation to ranking member Murray. EVIDENTIARY: No federal contracts per `get_government_precedent`; zero lobbying spend per `get_political_influence.lobbying`; congressional trading limited to sales by one member (P000595). Net: High-structure donor link offset by lack of broader financial footprint and evidentiary support.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Broad legislative pressure on pharmaceutical pricing and regulation.Congress"Eight recent bills with uniform 0.005 impact_ratio each, per `Recent bill_impacts` array."
Regulatory opportunities
-
Alignment with Senate HELP and LHHS Appropriations committees via donor relationship.Senate Committee on Health, Education, Labor, and Pensions (HELP); Senate Appropriations Subcommittee on LHHS"Donation recipient Sen. Patty Murray sits on HELP and ranks on LHHS Appropriations subcommittee per `get_political_influence.donations[0].committees`."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
Live signals + predictions for OGN — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades OGN
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord